Skip to main content
OpenTrials
Completed

NCT Number: NCT01212575

A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Aabenraa, Denmark

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with a diagnosis of schizophrenia from a district psychiatric clinic in Denmark
  • Patients who have received at least one dose of Seroquel XR or Seroquel IR during January - March 2010

Exclusion criteria

  • Patients already participating in a clinical study during the study-period.

Treatment and study plan

Primary outcomes

  1. How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia

    Time frame: Month 1

  2. How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia

    Time frame: Month 2

  3. How Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia

    Time frame: Month 3

Secondary outcomes

  1. Co-morbidities of patients with schizophrenia receiving Seroquel XR and IR

    Time frame: Month 1

  2. Co-morbidities of patients with schizophrenia receiving Seroquel XR and IR

    Time frame: Month 2

  3. Co-morbidities of patients with schizophrenia receiving Seroquel XR and IR

    Time frame: Month 3

  4. Whether Seroquel XR and Seroquel IR are used to treat different types of outpatients with schizophrenia by evaluation of patient characteristics

    Time frame: Month 1

  5. Whether Seroquel XR and Seroquel IR are used to treat different types of outpatients with schizophrenia by evaluation of patient characteristics

    Time frame: Month 2

  6. Whether Seroquel XR and Seroquel IR are used to treat different types of outpatients with schizophrenia by evaluation of patient characteristics

    Time frame: Month 3

  7. The treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR

    Time frame: Month 1

  8. The treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR

    Time frame: Month 2

  9. The treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR

    Time frame: Month 3

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Sep 30, 2010
Registry last updated
Mar 8, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.